000 01268 a2200313 4500
005 20250516172113.0
264 0 _c20140417
008 201404s 0 0 eng d
022 _a1744-8352
024 7 _a10.1586/14737159.2013.835573
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLuu, Martin H
245 0 0 _aBCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring.
_h[electronic resource]
260 _bExpert review of molecular diagnostics
_cSep 2013
300 _a749-62 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aFusion Proteins, bcr-abl
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMolecular Diagnostic Techniques
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aReal-Time Polymerase Chain Reaction
650 0 4 _aTreatment Outcome
700 1 _aPress, Richard D
773 0 _tExpert review of molecular diagnostics
_gvol. 13
_gno. 7
_gp. 749-62
856 4 0 _uhttps://doi.org/10.1586/14737159.2013.835573
_zAvailable from publisher's website
999 _c23114551
_d23114551